SecBot SecBot
144 ·Filed May 14, 2026

ECOR

electroCore, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed5mo ago SEC0001949846-26-000282
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a small, routine Form 144 filing by a director. The sale amount is immaterial relative to market cap and does not indicate distress. Monitor for actual execution on Form 4, but no immediate trading action warranted.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
ECOR ▲ +39.35% at T+60d
NEUTRAL call +39.35% · α vs SPY +35.76% · entry $6.43 → $8.96
Entry = T+0 close
May 14, 2026
via day close
T+1d
-2.49%
call -2.49% · α -1.26%
$6.27
settled 6mo ago
T+5d
-6.84%
call -6.84% · α -6.13%
$5.99
settled 5mo ago
T+20d
+59.41%
call +59.41% · α +60.27%
$10.25
settled 5mo ago
T+60d
+39.35%
call +39.35% · α +35.76%
$8.96
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Director Daniel S. Goldberger filed a Form 144 to sell 45,000 shares of electroCore common stock, valued at approximately $291,600 based on the filing date. This represents about 0.54% of the company's $52M market cap and is a relatively small, routine sale by an affiliate. The shares were acquired via equity compensation in 2021, and the filing signals intent to sell, not a completed transaction.

Key Facts

  • Insider: Daniel S. Goldberger (director, former affiliate)
  • Shares to be sold: 45,000 shares of common stock
  • Estimated value: $291,600 (based on filing date price ~$6.48)
  • Shares acquired via equity compensation on 6/30/2021
  • Sale represents ~0.54% of market cap ($52M)
  • Broker: Charles Schwab & Co.
  • Proposed sale date: 5/14/2026

Financial Impact

Up to $291,600 in insider selling, representing ~0.54% of market cap

insider holdingsfloat

Risk Factors

  • Insider selling may increase if additional Form 144s or Form 4s appear
  • Low liquidity could amplify price impact if sale is executed quickly

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
91% bullish (11 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001949846-26-000282
Document: 0001949846-26-000282-index.html0001949846-26-000282
Document: 0001949846-26-000282.txt0001949846-26-000282
9 reports for ECOR
Performance horizon
Filters
Rows
Reports for ECOR — sortable, filterable
TypeNow
Sep 9, 2026
6w ago
8-K
NEUTRAL ★ 3/10
$8.99 $9.72▲ +8.12%▲ +6.18%$7.44 (−17.24%)
May 27, 2026
21w ago
144
NEUTRAL ★ 2/10
$9.24 $7.19▼ −22.19%▼ −20.28%$7.44 (−19.48%)
May 14, 2026
23w ago
144
NEUTRAL ★ 2/10
$6.43 $10.25▲ +59.41%▲ +60.27%$7.44 (+15.71%)
May 5, 2026
24w ago
144
NEUTRAL ★ 4/10
$6.99 $9.45▲ +35.19%▲ +30.24%$7.44 (+6.44%)
Apr 29, 2026
25w ago
Press Release
NEUTRAL ★ 1/10
$6.15 $9.24▲ +50.24%▲ +44.78%$7.44 (+20.98%)
Apr 23, 2026
26w ago
144
NEUTRAL ★ 3/10
$6.18 $6.13▼ −0.81%▼ −5.44%$7.44 (+20.39%)
Apr 1, 2026
29w ago
Press Release
MIXED ★ 5/10
$6.60 $6.15▼ −6.82%▼ −16.54%$7.44 (+12.73%)
Mar 19, 2026
31w ago
Press Release
MIXED ★ 6/10
$6.25 $6.31▲ +0.96%▼ −8.36%$7.44 (+19.04%)
Mar 10, 2026
32w ago
Press Release
NEUTRAL ★ 3/10
$6.50 $6.21▼ −4.46%▼ −4.31%$7.44 (+14.46%)
Showing 9 of 9

US Market Status

Market Closed — Opens Wed (10h 12m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 14, 2026